1. [11beta-hydroxylase deficiency].
- Author
-
Mello MP, Penachioni JY, Amaral FC, and Castro Md
- Subjects
- Humans, Isoenzymes genetics, Isoenzymes metabolism, Steroid 11-beta-Hydroxylase genetics, Steroid 11-beta-Hydroxylase metabolism, Adrenal Hyperplasia, Congenital diagnosis, Adrenal Hyperplasia, Congenital drug therapy, Adrenal Hyperplasia, Congenital genetics, Adrenal Hyperplasia, Congenital metabolism
- Abstract
Congenital adrenal hyperplasia due to 11beta-hydroxylase enzyme deficiency is a result of the impairment of 11-deoxycortisol to cortisol conversion. In general, it is responsible for less than 5% of the congenital adrenal hyperplasia cases. The clinical expression of androgen excess in females includes several degrees of genital ambiguity, varying from clitoromegaly to complete virilization. Due to the accumulation of mineralocorticoids, approximately 50% of the patients develop blood hypertension. Mutations in the CYP11B1 gene are responsible for the disease. Biochemical and molecular characteristics of the enzyme and their implications in the clinical presentation of 11beta-hydroxylase deficiency are reviewed here.
- Published
- 2004
- Full Text
- View/download PDF